Biomarkers, designs, and interpretations of resting‐state fMRI in translational pharmacological research: A review of state‐of‐the‐Art, challenges, and opportunities for studying brain chemistry
Open Access
- 1 February 2017
- journal article
- review article
- Published by Wiley in Human Brain Mapping
- Vol. 38 (4) , 2276-2325
Abstract
A decade of research and development in resting‐state functional MRI (RSfMRI) has opened new translational and clinical research frontiers. This review aims to bridge between technical and clinical researchers who seek reliable neuroimaging biomarkers for studying drug interactions with the brain. About 85 pharma‐RSfMRI studies using BOLD signal (75% of all) or arterial spin labeling (ASL) were surveyed to investigate the acute effects of psychoactive drugs. Experimental designs and objectives include drug fingerprinting dose‐response evaluation, biomarker validation and calibration, and translational studies. Common biomarkers in these studies include functional connectivity, graph metrics, cerebral blood flow and the amplitude and spectrum of BOLD fluctuations. Overall, RSfMRI‐derived biomarkers seem to be sensitive to spatiotemporal dynamics of drug interactions with the brain. However, drugs cause both central and peripheral effects, thus exacerbate difficulties related to biological confounds, structured noise from motion and physiological confounds, as well as modeling and inference testing. Currently, these issues are not well explored, and heterogeneities in experimental design, data acquisition and preprocessing make comparative or meta‐analysis of existing reports impossible. A unifying collaborative framework for data‐sharing and data‐mining is thus necessary for investigating the commonalities and differences in biomarker sensitivity and specificity, and establishing guidelines. Multimodal datasets including sham‐placebo or active control sessions and repeated measurements of various psychometric, physiological, metabolic and neuroimaging phenotypes are essential for pharmacokinetic/pharmacodynamic modeling and interpretation of the findings. We provide a list of basic minimum and advanced options that can be considered in design and analyses of future pharma‐RSfMRI studies. Hum Brain Mapp 38:2276–2325, 2017. © 2017 Wiley Periodicals, Inc.Keywords
This publication has 355 references indexed in Scilit:
- A comparison of physiologic modulators of fMRI signalsHuman Brain Mapping, 2012
- Effects of alcohol intoxication and gender on cerebral perfusion: an arterial spin labeling studyAlcohol, 2011
- Nicotine effects on default mode network during resting statePsychopharmacology, 2011
- Distribution of cerebral blood flow in the caudate nucleus, lentiform nucleus and thalamus in patients with carotid artery stenosisEuropean Radiology, 2010
- Estimation of labeling efficiency in pseudocontinuous arterial spin labelingMagnetic Resonance in Medicine, 2010
- Continuous flow‐driven inversion for arterial spin labeling using pulsed radio frequency and gradient fieldsMagnetic Resonance in Medicine, 2008
- Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasksHuman Brain Mapping, 2008
- The effect of respiration variations on independent component analysis results of resting state functional connectivityHuman Brain Mapping, 2008
- Persistent default‐mode network connectivity during light sedationHuman Brain Mapping, 2008
- Spatial nonuniformity of the resting CBF and BOLD responses to sevoflurane: In vivo study of normal human subjects with magnetic resonance imagingHuman Brain Mapping, 2007